SuperworthKorro Bio shares outstanding KRRO
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 17.6M
- On a year earlier
- +87.6%
- more shares
Korro Bio had 17.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 87.6% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 9.4M | +1% |
| FY2024 | 9.4M | +1253% |
| FY2021 | 691.9K | +2% |
| FY2020 | 676.2K | +1902% |
| FY2018 | 33.8K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 17.6M | +88% | |
| Q1 FY26 | 11.6M | +24% | |
| Q4 FY25 | 9.4M | +1% | |
| Q3 FY25 | 9.4M | +1% | |
| Q2 FY25 | 9.4M | +4% | |
| Q1 FY25 | 9.4M | +17% | |
| Q4 FY24 | 9.4M | n/a | |
| Q3 FY24 | 9.3M | +3174% | |
| Q2 FY24 | 9M | +3150% | |
| Q1 FY24 | 8M | +2854% | |
| Q3 FY23 | 284.2K | −60% | |
| Q2 FY23 | 276.5K | −60% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Korro Bio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.